Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

| More on:
a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market may be charging higher today, but the same cannot be said for the Sigma Healthcare Ltd (ASX: SIG) share price.

The shares of the pharmacy chain distributor and operator, which is planning to merge with Chemist Warehouse, are down slightly to 1.5% to $1.20.

This follows the release of the company's full-year results this morning.

Sigma share price falls on results

  • Net revenue down 9.2% to $3.3 billion
  • EBITDA up 3.9% to $51.5 million
  • Net profit after tax up 149% to $4.5 million
  • Partially franked final dividend of 0.5 cents per share.

What happened in FY 2024?

For the 12 months ended 31 December, Sigma posted a 9.2% decline in net revenue to $3.3 billion. This reflects its decision to dispose of its hospital distribution business during the year and elevated sales of Rapid Antigen Tests in FY 2023 that have not repeated.

Nevertheless, the company's EBIT came in 20.4% higher year on year at $23.2 million, with reported net profit after tax increasing 149% to $4.5 million. This includes initial costs of $8.2 million relating to its proposed merger with Chemist Warehouse.

Excluding merger transaction costs, EBIT was $31.4 million and net profit after tax was $12.7 million for the year.

Management advised that it was able to deliver strong earnings growth despite its revenue decline thanks to efficiencies. Sigma's CEO and Managing Director, Vikesh Ramsunder, said:

With our operating performance strong, we have been able to drive efficiencies across our business, reducing total operating costs by 10.7% after absorbing merger proposal costs, providing a catalyst for our current and future financial performance. The company-wide simplification program and divestment of non-core assets has delivered a leaner operating model.

Outlook

The company has re-affirmed its medium-term EBIT target of 1.5% to 2.5% on a standalone basis.

This compares to its EBIT margin (before Chemist Warehouse merger costs) of 0.95% for FY 2024.

Chemist Warehouse merger update

Ramsunder spoke briefly about the proposed merger with Chemist Warehouse, once again reiterating the benefits of the move. He said:

This merger proposal is truly transformational for Sigma. It will diversify our earnings and growth profile whilst also creating opportunities for Sigma to enhance the support provided to pharmacy owners, helping them to profitably grow their business and better support their communities.

Sigma submitted its submission to the ACCC in February, and on 8 March the competition regulator commenced a public consultation process. Mr Ramsunder is hopeful that a decision on the merger could be made in the second half of 2024. He adds:

This is a significant and complex transaction which will require a detailed review by the regulator. There will be community interest and a wide consultation process which adds to the complexity of predicting timeframes. We are hopeful of a decision from the ACCC in the second half of the calendar year, which will precede a number of other steps required to reach completion.

Should you invest $1,000 in Sigma Healthcare right now?

Before you buy Sigma Healthcare shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Sigma Healthcare wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 9 January 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Up 1,090% in a year, why is the Mesoblast share price leaping higher again on Friday?

Mesoblast shares have surged more than 1,000% over the last 12 months.

Read more »

Man standing in a mine with mining vehicles.
Resources Shares

Sayona Mining share price charging higher on 33% revenue boost

ASX investors are reacting very positively to Sayona Mining’s December results.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Earnings Results

ResMed shares rise on strong Q2 result

Let's see how this sleep treatment company performed during the second quarter.

Read more »

two men in hard hats and high visibility jackets look together at a laptop screen that one of the men in holding at a mine site.
Earnings Results

IGO share price down 3% after 'challenges' in Q2 FY25

Investors have swiftly reacted to the news.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Earnings Results

Why this $1.2 billion ASX 200 stock is diving 6% today

Let's find out why investors are selling down this stock today.

Read more »

A wide-eyed man peers out from a small gap in his black zipped jumper conveying fear over the weak Zip share price
Earnings Results

Why did the Zip share price just crash 20%?

Up 275% in a year, Zip shares are getting smashed on Thursday. But why?

Read more »

Gold

2 ASX 200 gold stocks making moves on strong quarterlies

The ASX 200 gold stocks have benefited from a rising gold price.

Read more »

A man is shocked about the explosion happening out of his brain.
AI Stocks

Up 116% in a year, why is the Brainchip share price crashing 10% today?

ASX investors are sending the Brainchip share price plunging today. But why?

Read more »